Syneos Health - SYNH Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings or view top-rated stocks.

10 brokers have issued 1 year target prices for Syneos Health's shares. Their SYNH share price forecasts range from $25.00 to $81.00. On average, they predict the company's stock price to reach $53.60 in the next twelve months. This suggests a possible upside of 40.2% from the stock's current price.
View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts.

Syneos Health's stock was trading at $36.68 on January 1st, 2023. Since then, SYNH stock has increased by 4.2% and is now trading at $38.22.
View the best growth stocks for 2023 here.

Syneos Health saw a increase in short interest in January. As of January 15th, there was short interest totaling 7,250,000 shares, an increase of 19.6% from the December 31st total of 6,060,000 shares. Based on an average daily volume of 1,700,000 shares, the short-interest ratio is currently 4.3 days. Currently, 7.1% of the shares of the company are sold short.
View Syneos Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our SYNH earnings forecast.

Syneos Health, Inc. (NASDAQ:SYNH) announced its earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 14.01% and a net margin of 5.31%. The firm's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.93 EPS.

Syneos Health issued an update on its FY 2022 earnings guidance on Monday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $5.30 billion-$5.36 billion, compared to the consensus revenue estimate of $5.32 billion.

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Syneos Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Assenagon Asset Management S.A. (1.03%), Reinhart Partners Inc. (0.40%), New York State Common Retirement Fund (0.30%), Allspring Global Investments Holdings LLC (0.28%), Natixis Advisors L.P. (0.26%) and Envestnet Asset Management Inc. (0.15%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Paul Colvin, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends.

Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SYNH stock can currently be purchased for approximately $38.22.

Syneos Health (NASDAQ:SYNH) has a market capitalization of $3.93 billion and generates $5.21 billion in revenue each year. The company earns $234.83 million in net income (profit) each year or $2.75 on an earnings per share basis.

The company employs 28,000 workers across the globe.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.